HemaSphere (Aug 2023)

S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB

  • Juan Miguel Bergua Burgues,
  • Rebeca Rodríguez-Veiga,
  • Isabel Cano Ferri,
  • Ferran Vall-Llovera Calmet,
  • Antonio Garcia-Guiñon,
  • Joaquin Gomez Espuch,
  • Mercedes Colorado,
  • Ignacio Casas-Avilés,
  • Jordi Esteve,
  • Antonia Sampol,
  • Maria Victoria Verdugo,
  • Fernando Ramos,
  • Marta Valero,
  • Evelyn Gloria Acuña Cruz,
  • Blanca Boluda,
  • Laura Torres Miñana,
  • Joaquín Martinez-Lopez,
  • Eva Barragan,
  • Rosa Ayala Diaz,
  • David Martinez-Cuadrón,
  • Pau Montesinos

DOI
https://doi.org/10.1097/01.HS9.0000967440.83852.70
Journal volume & issue
Vol. 7
p. e8385270

Abstract

Read online

No abstracts available.